271 related articles for article (PubMed ID: 21183793)
1. Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma.
Staquicini FI; Ozawa MG; Moya CA; Driessen WH; Barbu EM; Nishimori H; Soghomonyan S; Flores LG; Liang X; Paolillo V; Alauddin MM; Basilion JP; Furnari FB; Bogler O; Lang FF; Aldape KD; Fuller GN; Höök M; Gelovani JG; Sidman RL; Cavenee WK; Pasqualini R; Arap W
J Clin Invest; 2011 Jan; 121(1):161-73. PubMed ID: 21183793
[TBL] [Abstract][Full Text] [Related]
2. Charting the course across the blood-brain barrier.
Nathanson D; Mischel PS
J Clin Invest; 2011 Jan; 121(1):31-3. PubMed ID: 21183784
[TBL] [Abstract][Full Text] [Related]
3. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
5. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme.
Sun P; Xiao Y; Di Q; Ma W; Ma X; Wang Q; Chen W
Int J Nanomedicine; 2020; 15():6673-6688. PubMed ID: 32982226
[TBL] [Abstract][Full Text] [Related]
6. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
7. Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
Wu J; Zhao J; Zhang B; Qian Y; Gao H; Yu Y; Wei Y; Yang Z; Jiang X; Pang Z
Int J Nanomedicine; 2014; 9():5261-71. PubMed ID: 25419130
[TBL] [Abstract][Full Text] [Related]
8. Targeted AAVP-based therapy in a mouse model of human glioblastoma: a comparison of cytotoxic versus suicide gene delivery strategies.
Staquicini FI; Smith TL; Tang FHF; Gelovani JG; Giordano RJ; Libutti SK; Sidman RL; Cavenee WK; Arap W; Pasqualini R
Cancer Gene Ther; 2020 May; 27(5):301-310. PubMed ID: 31130731
[TBL] [Abstract][Full Text] [Related]
9. Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
Ni XR; Zhao YY; Cai HP; Yu ZH; Wang J; Chen FR; Yu YJ; Feng GK; Chen ZP
J Neurooncol; 2020 Jun; 148(2):245-258. PubMed ID: 32405996
[TBL] [Abstract][Full Text] [Related]
10. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
12. Efflux transporters at the blood-brain barrier limit delivery and efficacy of cyclin-dependent kinase 4/6 inhibitor palbociclib (PD-0332991) in an orthotopic brain tumor model.
Parrish KE; Pokorny J; Mittapalli RK; Bakken K; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2015 Nov; 355(2):264-71. PubMed ID: 26354993
[TBL] [Abstract][Full Text] [Related]
13. A dual-targeting peptide for glioblastoma screened by phage display peptide library biopanning combined with affinity-adaptability analysis.
Li X; Pu X; Wang X; Wang J; Liao X; Huang Z; Yin G
Int J Pharm; 2023 Sep; 644():123306. PubMed ID: 37572856
[TBL] [Abstract][Full Text] [Related]
14. Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase.
Chitambar CR; Al-Gizawiy MM; Alhajala HS; Pechman KR; Wereley JP; Wujek R; Clark PA; Kuo JS; Antholine WE; Schmainda KM
Mol Cancer Ther; 2018 Jun; 17(6):1240-1250. PubMed ID: 29592883
[TBL] [Abstract][Full Text] [Related]
15. Pragmatic recruitment of memantine as the capping group for the design of HDAC inhibitors: A preliminary attempt to unravel the enigma of glioblastoma.
Nepali K; Hsu TI; Hsieh CM; Lo WL; Lai MJ; Hsu KC; Lin TE; Chuang JY; Liou JP
Eur J Med Chem; 2021 May; 217():113338. PubMed ID: 33744690
[TBL] [Abstract][Full Text] [Related]
16. Inducing a Transient Increase in Blood-Brain Barrier Permeability for Improved Liposomal Drug Therapy of Glioblastoma Multiforme.
Lundy DJ; Lee KJ; Peng IC; Hsu CH; Lin JH; Chen KH; Tien YW; Hsieh PCH
ACS Nano; 2019 Jan; 13(1):97-113. PubMed ID: 30532951
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
[TBL] [Abstract][Full Text] [Related]
18. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
19. Penetrating the Blood-Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy.
Tam DY; Ho JW; Chan MS; Lau CH; Chang TJH; Leung HM; Liu LS; Wang F; Chan LLH; Tin C; Lo PK
ACS Appl Mater Interfaces; 2020 Jul; 12(26):28928-28940. PubMed ID: 32432847
[TBL] [Abstract][Full Text] [Related]
20. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma.
Agemy L; Friedmann-Morvinski D; Kotamraju VR; Roth L; Sugahara KN; Girard OM; Mattrey RF; Verma IM; Ruoslahti E
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17450-5. PubMed ID: 21969599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
